MiNK Therapeutics INKT
NASDAQ INKT
$12.44 -0.29 (-2.28%)
At close: Oct 2, 2026 · 4:00 PM EDT

MiNK Therapeutics (INKT) Cash from Investing Activities (2021 - 2023)

Updated

MiNK Therapeutics (INKT) reported Cash from Investing Activities of -$73,561 for FY2023, compared with -$250,046 in FY2022.

Analysis

MiNK Therapeutics (INKT) Cash from Investing Activities (2021 - 2023) Analysis & Trends

Dating back to FY2020, MiNK Therapeutics' Cash from Investing Activities record includes 4 years.

  • According to Business Quant data, Cash from Investing Activities came in at -$250,046 in FY2022, -$248,983 in FY2021 and -$95,212 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 MiNK Therapeutics 63.40 Mn 63.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -23,043.00
Jun 30, 2023 -37,018.00
Mar 31, 2023 -13,500.00
Dec 31, 2022 -127,838.00
Sep 30, 2022 -59,795.00
Dec 31, 2021 277.00
Sep 30, 2021 -111,820.00
Jun 30, 2021 -97,920.00
Mar 31, 2021 -39,520.00
API Access

MiNK Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=INKT&period=max&api_key=YOUR_API_KEY